U.S. Healthtech Stock News

Consumer-protection lawsuit filed against lululemon athletica alleging improper retention of tariff-linked price increases. Case claims the company has pursued recovery of now-invalidated tariffs without committing to refund affected customers. Legal action raises questions about consumer treatment, potential financial liability, and brand impact for NasdaqGS:LULU. Lululemon athletica, traded on NasdaqGS:LULU, is facing fresh legal scrutiny that lands at a sensitive time for the stock...

Merger call puts Patrick Industries in focus Patrick Industries (PATK) is drawing fresh attention after scheduling a call to discuss a definitive agreement for an all stock merger with LCI Industries. This potential combination could significantly influence the company’s future footprint. See our latest analysis for Patrick Industries. Alongside the merger announcement and recent additions to several Russell value indices, Patrick Industries’ share price has slipped 3.65% over the past day...

In late June 2026, U-Haul Holding Company was removed from several Russell 1000 classifications, including the Growth-Defensive, Defensive, and Value-Defensive indices for both its UHAL and UHAL.B share classes. This broad index exclusion highlights how U-Haul’s investment profile is now being reassessed by index providers, which can influence how passive and quantitative investors view the stock. With U-Haul’s removal from multiple Russell 1000 defensive-style indices, we’ll examine how...

U.S. Department of Energy approves the final Documented Safety Analysis for Oklo's Groves Isotope Test Reactor. The reactor now moves into the last pre-startup review phase ahead of potential first criticality. Approval positions Oklo to pursue domestic commercial production of critical medical and industrial isotopes. For investors watching NYSE:OKLO, this regulatory sign off arrives while the stock trades at $52.33 and has had mixed recent returns. The share price is down 8.5% over the...

Eos Energy Enterprises (NasdaqCM:EOSE) agreed to a $75 million direct offering and a $150 million rights distribution tied to its Frontier Power USA joint venture. The financing package is designed to support long duration energy storage projects and a project pipeline linked to more than $1.5b in potential financing. New institutional partners are providing direct equity commitments that reshape the company's capital structure and funding options. Eos Energy Enterprises comes into this...

Digital Realty Trust (DLR) just completed a US$2.28b follow on equity offering of common stock, a financing move that gives investors fresh information on capital allocation and potential dilution at the current share price. See our latest analysis for Digital Realty Trust. Digital Realty Trust shares have come under pressure around the follow on equity offering and recent Northern Virginia and Kansas City data center deals, with the share price down 5.8% on the day and 7.9% over the past...

Expedia Group stock has delivered a strong 129.7% return over the past three years, so the current question is whether that performance is still backed up by what the valuation checks are saying or whether expectations are starting to run ahead of the fundamentals. Over three years, Expedia Group has returned 129.7%, which puts added weight on whether today’s price still offers enough compensation for risk. Recent research on fully connected hotels and an expanded platform that can benefit...

Bristol-Myers Squibb (BMY) is being reclassified across key Russell indexes, exiting several growth benchmarks and entering the Russell 1000 Defensive and Russell 1000 Value Defensive Indexes, a shift that can influence passive fund positioning. See our latest analysis for Bristol-Myers Squibb. At a share price of US$57.62, Bristol-Myers Squibb has a year to date share price return of 7.78%, while its 1 year total shareholder return of 27.34% contrasts with a 6.66% decline over 90 days. This...

ResMed stock has fallen 23.2% over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiples currently point to the shares trading at a discount to what the business may be worth. Over the last 12 months the share price declined 23.2%, which means the market has already reset expectations even as valuation indicators lean supportive. Recent coverage has highlighted recurring revenue from sleep apnea devices and software as a potential support...

Quanta Services has delivered a very large 5 year gain of about 7x, yet the stock now screens as expensive, with a low value score and market multiples pointing to an overvalued profile despite the strong operational story around power and AI related infrastructure. Over the last 5 years, Quanta Services has returned roughly 725%, which puts extra focus on whether the current share price already reflects much of the good news. Expectations for continued demand tied to grid modernization and...

Rocket Lab stock has delivered a very large 3 year gain, yet the valuation checks now point to a richer pricing, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples indicating the shares trade at a premium rather than a clear bargain. Over the past 3 years, Rocket Lab has returned about 16x, which sets a high bar for any further upside to be justified by future cash flows. The planned acquisition of Iridium Communications and expansion into vertically...

Evolv Technologies Holdings (EVLV) drew fresh investor attention after announcing a multi-year renewal and upgrade of its hardware and software subscription agreement with TD Garden, reinforcing its role in the arena’s security screening operations. See our latest analysis for Evolv Technologies Holdings. At a share price of $5.80, Evolv Technologies Holdings has seen a 1-day share price return of 3.39% and a 7-day share price return of 4.69%. The 30-day share price return is down 10.08% and...

India’s driest June in 12 years, with rainfall nearly 40% below forecast and sharp drops in rice and oilseed sowing, is reshaping expectations for global agriculture and food trade. When a major buyer like India faces weaker crop output, attention often shifts to exporters that can step in to meet demand for staples such as rice, edible oils, pulses, and grains. This article examines how that shock filters through to large listed agriculture and food exporters and highlights 3 stocks from our...

Fresh attention on Pilgrim's Pride (PPC) follows recent analyst coverage citing weaker earnings estimates and a lower rating, while revenue figures have shown some improvement and sentiment remains cautious. See our latest analysis for Pilgrim's Pride. At a share price of $28.11, Pilgrim's Pride has seen short term share price pressure, including a 1 day share price return that declined 2.9%, while the 3 year total shareholder return of 53.2% and 5 year total shareholder return of 51.72% show...

In June 2026, Teva Pharmaceutical Industries announced it had submitted a New Drug Application to the FDA for ecopipam, a first-in-class dopamine D1 receptor antagonist for pediatric Tourette syndrome, supported by positive Phase 3 data published in JAMA Neurology and Orphan Drug and Fast Track designations. The filing positions Teva to potentially introduce the first new FDA-approved pediatric Tourette syndrome treatment in more than a decade, extending its focus on neurology and rare...

NXP Semiconductors appointed Mike Lucarelli as Head of Investor Relations, succeeding retiring Senior VP Jeff Palmer. The change follows Palmer's long tenure leading the company's engagement with the investment community. Lucarelli brings extensive finance and sell side experience to the role, with a mandate to manage NXP Semiconductors' messaging to investors. NXP Semiconductors, listed as NasdaqGS:NXPI, is making this leadership change at a time when its stock has seen mixed short term...

Aveanna Healthcare Holdings recently delivered its fourth consecutive beat-and-raise quarter and completed the acquisition of Family First Holding, expanding its multi-state pediatric home care footprint. This combination of consistent earnings outperformance and a larger pediatric platform reinforces Aveanna’s positioning as a value-focused home care provider. Next, we’ll examine how Aveanna’s latest earnings beat and Family First acquisition may reshape the company’s broader investment...

Republic Services (RSG) has been in focus after reporting first quarter results that beat analyst expectations on adjusted operating income. The company also received supportive analyst ratings and regulatory approval to acquire TD*X Associates assets. See our latest analysis for Republic Services. The recent 6.3% 1 month share price return and 1.9% 7 day share price gain for Republic Services suggest firming momentum, even as the 1 year total shareholder return is down 12% and longer term 3...

The Supreme Court’s backing of the Federal Reserve’s independence, at a time when inflation sits above 4% and rate hikes are on the table, puts interest rate policy firmly in the spotlight for bank investors. Higher rates can reshape funding costs, loan demand, and profit margins, which matters directly for larger US, UK, and Canadian banks with solid balance sheets. This article explains how that backdrop connects to our Banking Sector Stocks screener and highlights 3 stocks that appear well...

Why NIO Stock Is Back in Focus After June Delivery Update NIO (NIO) reported 40,597 vehicle deliveries in June 2026 and 107,658 for the second quarter, with the stock reacting as investors weighed record monthly volume against a quarterly total that missed earlier guidance. See our latest analysis for NIO. The latest delivery update landed against a mixed price backdrop for NIO, with the 1-day share price return of 2.22% standing out against a 30-day share price return down 9.64% and a 5-year...

Recent Performance Snapshot for John B. Sanfilippo & Son Stock John B. Sanfilippo & Son (JBSS) has drawn attention after a recent daily decline of 2.8%, even as the stock shows gains of 5.3% over the past week and about 15% over the past month. Investors are weighing that short term pullback against year to date and 1 year total returns of 23.2% and 37.3% respectively, alongside a reported market value of about US$1.0b and annual revenue of US$1,164.3m. See our latest analysis for John B...

American Express (AXP) is back in focus after Piper Sandler initiated coverage of the payments and consumer finance sector, highlighting the company alongside other large card issuers as a key holding in the group. See our latest analysis for American Express. Recent moves around American Express, including its planned acquisition of TheFork, new Membership Rewards redemptions through Apple Pay, and participation in the Open USD stablecoin initiative, have come alongside a 30 day share price...

Analyst upgrade puts Travel + Leisure in focus Travel + Leisure (TNL) is back on investor watchlists after Goldman Sachs upgraded the stock to Buy, citing steady, recurring fee income and a constructive view on the timeshare sector supported by healthy U.S. travel demand. See our latest analysis for Travel + Leisure. Beyond the analyst upgrade, Travel + Leisure’s recent move to a new Orlando headquarters and workplace recognition have coincided with solid momentum, with a 12.4% 30 day share...

Dow Inc. has come under pressure in recent weeks, with the stock lagging both the broader market and the Basic Materials sector while investors wait for its July 23, 2026 earnings report. At the same time, valuation models such as discounted cash flow and price-to-sales suggest the company may be trading below its estimated fair value, sharpening attention on whether upcoming results will bridge the gap between perception and fundamentals. Against this backdrop of sustained share weakness...